Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
5530 | 1545 | 33.6 | 62% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANTIANEMIC AGENTS | Author keyword | 11 | 100% | 0% | 6 |
2 | CAS 11096 26 7 | Author keyword | 9 | 83% | 0% | 5 |
3 | RECOMBINANT HUMAN ERYTHROPOIETIN RHEPO | Author keyword | 4 | 47% | 0% | 7 |
4 | ADV LIFE MED SCI | Address | 3 | 60% | 0% | 3 |
5 | ERYTHROPOIETIN MRNA | Author keyword | 3 | 60% | 0% | 3 |
6 | ERYTHROCYTOSIS | Author keyword | 3 | 11% | 1% | 23 |
7 | EPOETIN KAPPA | Author keyword | 2 | 67% | 0% | 2 |
8 | EQUINE DRUG TESTING PROGRAM | Address | 2 | 67% | 0% | 2 |
9 | ERYTHROPOIETIN GENE | Author keyword | 2 | 67% | 0% | 2 |
10 | IMMATURE RETICULOCYTES | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIANEMIC AGENTS | 11 | 100% | 0% | 6 | Search ANTIANEMIC+AGENTS | Search ANTIANEMIC+AGENTS |
2 | CAS 11096 26 7 | 9 | 83% | 0% | 5 | Search CAS+11096+26+7 | Search CAS+11096+26+7 |
3 | RECOMBINANT HUMAN ERYTHROPOIETIN RHEPO | 4 | 47% | 0% | 7 | Search RECOMBINANT+HUMAN+ERYTHROPOIETIN+RHEPO | Search RECOMBINANT+HUMAN+ERYTHROPOIETIN+RHEPO |
4 | ERYTHROPOIETIN MRNA | 3 | 60% | 0% | 3 | Search ERYTHROPOIETIN+MRNA | Search ERYTHROPOIETIN+MRNA |
5 | ERYTHROCYTOSIS | 3 | 11% | 1% | 23 | Search ERYTHROCYTOSIS | Search ERYTHROCYTOSIS |
6 | EPOETIN KAPPA | 2 | 67% | 0% | 2 | Search EPOETIN+KAPPA | Search EPOETIN+KAPPA |
7 | ERYTHROPOIETIN GENE | 2 | 67% | 0% | 2 | Search ERYTHROPOIETIN+GENE | Search ERYTHROPOIETIN+GENE |
8 | IMMATURE RETICULOCYTES | 2 | 67% | 0% | 2 | Search IMMATURE+RETICULOCYTES | Search IMMATURE+RETICULOCYTES |
9 | RECOMBINANT HUMAN EPO | 2 | 67% | 0% | 2 | Search RECOMBINANT+HUMAN+EPO | Search RECOMBINANT+HUMAN+EPO |
10 | WGA AFFINITY CHROMATOGRAPHY | 2 | 67% | 0% | 2 | Search WGA+AFFINITY+CHROMATOGRAPHY | Search WGA+AFFINITY+CHROMATOGRAPHY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ISOELECTRIC PROFILES | 34 | 79% | 1% | 22 |
2 | IMMUNOREACTIVE ERYTHROPOIETIN | 17 | 31% | 3% | 45 |
3 | HUMAN SERUM ERYTHROPOIETIN | 15 | 67% | 1% | 14 |
4 | SERUM IMMUNOREACTIVE ERYTHROPOIETIN | 12 | 32% | 2% | 31 |
5 | RENAL ERYTHROPOIETIN | 11 | 78% | 0% | 7 |
6 | ELECTROPHORESIS ELECTROSPRAY TIME | 9 | 67% | 1% | 8 |
7 | URINARY ERYTHROPOIETINS | 8 | 70% | 0% | 7 |
8 | PERITUBULAR CELLS | 8 | 23% | 2% | 29 |
9 | IMMUNOBLOTTING PROCEDURES | 6 | 71% | 0% | 5 |
10 | PERFUSED RAT KIDNEYS | 6 | 43% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ERYTHROPOIETIN - STRUCTURE, CONTROL OF PRODUCTION, AND FUNCTION | 1992 | 768 | 473 | 49% |
Regulation of erythropoietin production | 2011 | 72 | 67 | 27% |
ERYTHROPOIETIN | 1991 | 931 | 122 | 43% |
Regulation of the erythropoietin gene | 1999 | 218 | 185 | 37% |
Monitoring recombinant human erythropoietin abuse among athletes | 2015 | 2 | 96 | 30% |
Recent developments in doping testing for erythropoietin | 2011 | 21 | 97 | 66% |
Molecular biology of erythropoietin | 2004 | 194 | 175 | 33% |
Detection of peptidic erythropoiesis-stimulating agents in sport | 2014 | 2 | 29 | 72% |
Hypoxia-induced erythropoietin production: A paradigm for oxygen-regulated gene expression | 2006 | 76 | 139 | 35% |
Proinflammatory cytokines lowering erythropoietin production | 1998 | 159 | 54 | 28% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADV LIFE MED SCI | 3 | 60% | 0.2% | 3 |
2 | EQUINE DRUG TESTING PROGRAM | 2 | 67% | 0.1% | 2 |
3 | PHYS ANALYT CHEM SUR E BIOTECHNOL | 2 | 67% | 0.1% | 2 |
4 | SECT DOPING ANAL | 2 | 67% | 0.1% | 2 |
5 | SUISSE ANAL DOPAGE | 2 | 23% | 0.5% | 7 |
6 | STEREOSCOP MEDIA | 1 | 100% | 0.1% | 2 |
7 | NORWEGIAN DOPING CONTROL | 1 | 24% | 0.3% | 5 |
8 | CONTROLE DOPAGE | 1 | 33% | 0.2% | 3 |
9 | UNIV ROMAND MED LEGALE | 1 | 21% | 0.3% | 5 |
10 | CHINA DOPING CONTROL | 1 | 33% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000218618 | NUCLEATED RED BLOOD CELLS//NUCLEATED RED BLOOD CELL//NUCLEATED RED BLOOD CELL COUNT |
2 | 0.0000184772 | ERYTHROPOIETIN RECEPTOR//STEM PROGENITOR CELL BIOL PROGRAM//ERYTHROBLAST MACROPHAGE PROTEIN |
3 | 0.0000158919 | POSTTRANSPLANT ERYTHROCYTOSIS//POST TRANSPLANT ERYTHROCYTOSIS//ERYTHROCYTOSIS |
4 | 0.0000137042 | ERYTHROPOIETIN//DARBEPOETIN ALFA//RENAL ANEMIA |
5 | 0.0000130133 | HEREDITARY NEPHROTIC MOUSE ICGN//ICGN MOUSE//ICGN MICE |
6 | 0.0000120694 | B B RAT//CFU SD8//BURST PROMOTING ACTIVITY |
7 | 0.0000117373 | CHEMOTHERAPY INDUCED ANEMIA//EPOETIN ALFA//CHEMOTHERAPY INDUCED ANAEMIA |
8 | 0.0000110512 | ERYTHROPOIETIN//CELLULAR MOL CEREBRAL I EMIA//CARBAMYLATED ERYTHROPOIETIN |
9 | 0.0000104313 | ALTITUDE TRAINING//BLOOD DOPING//HEMOGLOBIN MASS |
10 | 0.0000067322 | ANEMIA OF PREMATURITY//PLACENTAL TRANSFUSION//ANAEMIA OF PREMATURITY |